265 related articles for article (PubMed ID: 34900128)
1. Atomic-scale insights into allosteric inhibition and evolutional rescue mechanism of
Li X; Wang C; Peng T; Chai Z; Ni D; Liu Y; Zhang J; Chen T; Lu S
Comput Struct Biotechnol J; 2021; 19():6108-6124. PubMed ID: 34900128
[TBL] [Abstract][Full Text] [Related]
2. Cas9 Allosteric Inhibition by the Anti-CRISPR Protein AcrIIA6.
Fuchsbauer O; Swuec P; Zimberger C; Amigues B; Levesque S; Agudelo D; Duringer A; Chaves-Sanjuan A; Spinelli S; Rousseau GM; Velimirovic M; Bolognesi M; Roussel A; Cambillau C; Moineau S; Doyon Y; Goulet A
Mol Cell; 2019 Dec; 76(6):922-937.e7. PubMed ID: 31604602
[TBL] [Abstract][Full Text] [Related]
3. Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins.
Hynes AP; Rousseau GM; Agudelo D; Goulet A; Amigues B; Loehr J; Romero DA; Fremaux C; Horvath P; Doyon Y; Cambillau C; Moineau S
Nat Commun; 2018 Jul; 9(1):2919. PubMed ID: 30046034
[TBL] [Abstract][Full Text] [Related]
4. Dairy phages escape CRISPR defence of Streptococcus thermophilus via the anti-CRISPR AcrIIA3.
Pastuszka A; Rousseau GM; Somerville V; Levesque S; Fiset JP; Goulet A; Doyon Y; Moineau S
Int J Food Microbiol; 2023 Dec; 407():110414. PubMed ID: 37778080
[TBL] [Abstract][Full Text] [Related]
5. Versatile and robust genome editing with
Agudelo D; Carter S; Velimirovic M; Duringer A; Rivest JF; Levesque S; Loehr J; Mouchiroud M; Cyr D; Waters PJ; Laplante M; Moineau S; Goulet A; Doyon Y
Genome Res; 2020 Jan; 30(1):107-117. PubMed ID: 31900288
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.
Song G; Zhang F; Tian C; Gao X; Zhu X; Fan D; Tian Y
Nucleic Acids Res; 2022 Mar; 50(5):2836-2853. PubMed ID: 35188577
[TBL] [Abstract][Full Text] [Related]
7. Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.
Jiang F; Liu JJ; Osuna BA; Xu M; Berry JD; Rauch BJ; Nogales E; Bondy-Denomy J; Doudna JA
Mol Cell; 2019 Feb; 73(3):601-610.e5. PubMed ID: 30595438
[TBL] [Abstract][Full Text] [Related]
8. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
[TBL] [Abstract][Full Text] [Related]
9. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
[TBL] [Abstract][Full Text] [Related]
10. Anti-CRISPR AcrIIC3 discriminates between Cas9 orthologs via targeting the variable surface of the HNH nuclease domain.
Kim Y; Lee SJ; Yoon HJ; Kim NK; Lee BJ; Suh JY
FEBS J; 2019 Dec; 286(23):4661-4674. PubMed ID: 31389128
[TBL] [Abstract][Full Text] [Related]
11. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
Sapranauskas R; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
Nucleic Acids Res; 2011 Nov; 39(21):9275-82. PubMed ID: 21813460
[TBL] [Abstract][Full Text] [Related]
12. A truncated anti-CRISPR protein prevents spacer acquisition but not interference.
Philippe C; Morency C; Plante PL; Zufferey E; Achigar R; Tremblay DM; Rousseau GM; Goulet A; Moineau S
Nat Commun; 2022 May; 13(1):2802. PubMed ID: 35589712
[TBL] [Abstract][Full Text] [Related]
13. Intrinsic disorder is essential for Cas9 inhibition of anti-CRISPR AcrIIA5.
An SY; Ka D; Kim I; Kim EH; Kim NK; Bae E; Suh JY
Nucleic Acids Res; 2020 Jul; 48(13):7584-7594. PubMed ID: 32544231
[TBL] [Abstract][Full Text] [Related]
14. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a Type II-A CRISPR-Cas System in
Mosterd C; Moineau S
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581075
[No Abstract] [Full Text] [Related]
16. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4.
Li X; Liao F; Gao J; Song G; Zhang C; Ji N; Wang X; Wen J; He J; Wei Y; Zhang H; Li Z; Yu G; Yin H
Nucleic Acids Res; 2023 Sep; 51(17):9442-9451. PubMed ID: 37587688
[TBL] [Abstract][Full Text] [Related]
18. An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9.
Hynes AP; Rousseau GM; Lemay ML; Horvath P; Romero DA; Fremaux C; Moineau S
Nat Microbiol; 2017 Oct; 2(10):1374-1380. PubMed ID: 28785032
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
[TBL] [Abstract][Full Text] [Related]
20. Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9.
Barkau CL; O'Reilly D; Rohilla KJ; Damha MJ; Gagnon KT
Nucleic Acid Ther; 2019 Jun; 29(3):136-147. PubMed ID: 30990769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
